title: Novel agent for Helicobacter pylori infection management.
authors.affiliation: Biotechnology Research Center, Students Research Committee, Faculty of Pharmacy, Tabriz University (Medical Sciences), Tabriz, Iran.
authors.forename: Ramin
authors.initials: R
authors.lastname: Mohammadzadeh
authors.forename: Nejla
authors.initials: N
authors.lastname: Ahmadiyan
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004926:Escherichia coli; D005260:Female; D005699:Galactosylceramides / Q000276:immunology*; D005753:Gastric Mucosa / Q000473:pathology*; D005757:Gastritis, Atrophic / Q000473:pathology*; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D007249:Inflammation / Q000473:pathology*; D007422:Intestines / Q000382:microbiology*; D064704:Levofloxacin; D008213:Lymphocyte Activation; D008297:Male; D055611:Natural Killer T-Cells / Q000382:microbiology*; D015242:Ofloxacin / Q000008:administration & dosage*; D020578:Sphingomonas; D013270:Stomach / Q000473:pathology*
chemical_list: D000900:Anti-Bacterial Agents; D005699:Galactosylceramides; D064704:Levofloxacin; D015242:Ofloxacin